STOCK TITAN

Ufp Technologies - UFPT STOCK NEWS

Welcome to our dedicated page for Ufp Technologies news (Ticker: UFPT), a resource for investors and traders seeking the latest updates and insights on Ufp Technologies stock.

UFP Technologies, Inc. (UFPT) delivers innovative custom-engineered solutions for medical device manufacturers and industrial partners through advanced material science and precision manufacturing. This news hub provides investors and industry professionals with direct access to UFPT's official announcements and strategic developments.

Track all corporate communications including quarterly earnings, product innovation launches, and strategic partnerships. Our curated collection features regulatory filings, manufacturing process advancements, and market expansion updates essential for understanding UFPT's position in specialty packaging and component manufacturing.

Key updates cover medical sector innovations, new material applications, and OEM collaboration milestones. Stay informed about UFPT's patented technologies and engineering capabilities that drive solutions for minimally invasive surgery, implant packaging, and aerospace components.

Bookmark this page for real-time updates on UFPT's operational developments and industry leadership. Regularly refreshed content ensures you maintain current awareness of this critical supply chain partner's evolving market role.

Rhea-AI Summary

UFP Technologies (Nasdaq: UFPT) has announced its participation in the CJS Securities 24th Annual New Ideas Summer Conference. The event is scheduled for July 10, 2024, at the Metropolis Country Club in White Plains, NY. UFP Technologies' Chairman and CEO, R. Jeffrey Bailly, along with CFO Ron Lataille, will present and participate in one-on-one meetings. The company, known for its innovative design and manufacturing of components and packaging for the medical market, aims to showcase its latest developments and engage with potential investors and partners.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.84%
Tags
conferences
-
Rhea-AI Summary

UFP Technologies (Nasdaq: UFPT) has acquired AJR Enterprises for $110 million.

AJR, based in Illinois and the Dominican Republic, specializes in single-use safe patient handling systems and generated sales of $75 million in the last 12 months ending March 31, 2024.

The acquisition aims to enhance UFP's patient surfaces portfolio, leveraging AJR's 'cut and sew' services and specialty fabrics expertise.

This strategic move aligns with UFP's goal to expand capabilities and provide comprehensive development, commercialization, and manufacturing services.

The transaction was financed through UFP's amended credit agreement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.56%
Tags
-
Rhea-AI Summary

UFP Technologies (UFPT) announced that its top executives, Chairman & CEO Jeffrey Bailly and Sr. Vice President & CFO Ron Lataille, will present at the 14th Annual East Coast IDEAS Investor Conference on June 12, 2024. The event will take place at Jay Conference – Bryant Park in New York, NY, and UFPT's presentation is scheduled for 4:10 PM ET. The presentation will be webcast and accessible through the conference host's main website and the investor relations section of the company's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.48%
Tags
conferences
Rhea-AI Summary

UFP Technologies, Inc. announced record Q1 results with net income of $12.7 million, up from $9.7 million in Q1 2023. Net sales increased to $105.0 million. The company saw organic sales growth in MedTech and Advanced Components businesses, with operating income and net income up by 24% and 30%, respectively. Gross margins improved, and the company is optimistic about future growth with active acquisition opportunities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.52%
Tags
none
-
Rhea-AI Summary
UFP Technologies, Inc. (UFPT) announced participation in KeyBanc Capital Markets 4th Annual Life Sciences and MedTech Investor Forum. Chairman R. Jeffrey Bailly and CFO Ron Lataille will present virtually on March 20, 2024, at 9:45 AM ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.58%
Tags
conferences
-
Rhea-AI Summary
UFP Technologies, Inc. (UFPT) reports impressive financial results for the year 2023, with a net income of $44.9 million and net sales of $400.1 million, marking a 13.1% increase from the previous year. The company also saw growth in the fourth quarter, with net income of $11.6 million and sales of $101.5 million, showcasing a positive outlook for future expansion and acquisitions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.45%
Tags
none
Rhea-AI Summary
UFP Technologies, Inc. announces the appointment of Mitchell Rock as President of the Company. Rock has been serving as President of the Company’s MedTech business. R. Jeffrey Bailly will continue in his capacity as Chairman and Chief Executive Officer. The Company is an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market. UFP Technologies is a key link in the medical device supply chain and a valued outsource partner to many top medical device manufacturers worldwide. The Company’s single-use and single-patient devices and components are used in a wide range of medical devices and packaging for various medical applications.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.08%
Tags
none
-
Rhea-AI Summary
UFP Technologies, Inc. (Nasdaq: UFPT) announced that Chairman and CEO R. Jeffrey Bailly and CFO Ron Lataille will participate in the CJS Securities 24th Annual 'New Ideas for the New Year' Conference on January 10, 2024. The presentation is set to begin at 11:45 AM ET. UFP Technologies is an innovative designer and custom manufacturer primarily for the medical market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
conferences
-
Rhea-AI Summary
UFP Technologies, Inc. (UFPT) to participate in Piper Sandler 35th Annual Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
conferences
Rhea-AI Summary
UFP Technologies, Inc. (Nasdaq: UFPT) reported a 13.8% increase in adjusted net income to $11.9 million in Q3 2023 compared to Q3 2022. Sales for Q3 were $100.8 million, up from $97.0 million in Q3 2022. For the nine-month period ended September 30, 2023, adjusted net income increased 44.4% to $35.8 million, with sales of $298.6 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.35%
Tags
Ufp Technologies

Nasdaq:UFPT

UFPT Rankings

UFPT Stock Data

1.62B
7.25M
5.72%
104.58%
13.37%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
NEWBURYPORT